[2022] Bashyal N., et al., Improving the safety of mesenchymal stem cell-based ex vivo therapy using Herpes Simplex virus thymidine kinase. Mol. Cells. 2022, 5:479-494.
작성자
admin
작성일
2025-07-29 14:54
조회
1210
📄 Title
Improving the safety of mesenchymal stem cell-based ex vivo therapy using Herpes Simplex virus thymidine kinase
👤 Authors
Bashyal N et al.
📚 Journal
Molecules and Cells
📅 Year
2022
📑 Vol. 5: 479–494
🔗 Link
Improving the safety of mesenchymal stem cell-based ex vivo therapy using Herpes Simplex virus thymidine kinase
전체 13